10x Genomics, Inc. (TXG)
NASDAQ: TXG · IEX Real-Time Price · USD
16.70
+0.14 (0.85%)
At close: Jul 19, 2024, 4:00 PM
17.40
+0.70 (4.19%)
Pre-market: Jul 22, 2024, 7:25 AM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.00 billion as of July 22, 2024. Its market cap has decreased by -67.52% in one year.
Market Cap
2.00B
Enterprise Value
1.72B
1-Year Change
-67.52%
Ranking
Category
Stock Price
$16.70
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.90B to $2.00B, a decrease of -59.18%. That is a compound annual growth rate of -16.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.00B | -69.78% |
| Dec 29, 2023 | 6.62B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | 7.33B | 49.72% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 2.09B |
| Rocket Pharmaceuticals | 2.07B |
| Premier | 2.05B |
| BrightSpring Health Services | 2.00B |
| Catalyst Pharmaceuticals | 2.00B |
| Edgewise Therapeutics | 1.99B |
| Immunocore Holdings | 1.99B |
| Recursion Pharmaceuticals | 1.99B |